Id,Section,ui,Label,Enumeration,Notes,min,max,branching_logic,Unit,CDE Reference
study_id,Identity,text,RADx-rad Study ID; Subject ID; Datavent ID,,,,,,,RADx-rad Minimum CDE
chills,Symptoms,radio,Chills,Will not collect,,,,,,RADx-rad Minimum CDE
diarrhea,Symptoms,radio,Diarrhea,"1, Yes | 0, No",,,,,,RADx-rad Minimum CDE
covid_vaccine,Vaccine Acceptance,radio,Have you received a COVID-19 vaccine?,"1, Yes | 0, No | 98,  not sure/prefer not to answer",,,,,,RADx-rad DCC
covid_vaccine_doses,Vaccine Acceptance,integer,How many COVID-19 vaccine doses have you received?,,"use 0 if covid_vaccine == 0, leave blank if covid_vaccine == 98",,,,,RADx-rad DCC
covid_test_target_disease_status,Covid Testing,radio,Participant Testing Disease Status,"1, Asymptomatic | 2, Pre-symptomatic illness | 3, Mild/Moderate outpatient illness | 4, Acute illness | 5, Severe/Critical inpatient illness| 6, Exposed | 9, Convalescent illiness",,,,,,RADx-UP Testing Core
covid_test_type,Covid Testing,radio,Test Method Target,"1, Antibody | 2, Antigen | 3, Nucleic acid/PCR | 4, Nucleic acid/Isothermal | 5, Molecular/host response | 6, Biochemical marker (eg, pH) | 90, Other, Specify",,,,,,RADx-UP Testing Core
covid_test_type_other,Covid Testing,text,Other method target,,,,,"[covid_test_type] = ""90""",,RADx-UP Testing Core
covid_test_name,Covid Testing,text,Test manufacturer (or LDT) and test name,,,,,,,RADx-UP Testing Core
covid_test_ct_value,Covid Testing,integer,PCR cycle threshold,,,,,,,RADx-rad DCC
covid_test_specimen_type,Covid Testing,radio,Specimen Type,"1, Anterior nasal swab | 2, Mid-turbinate nasal swab | 3, Nasopharyngeal swab | 4, Oropharyngeal swab | 5, Nasal lavage | 6, Saliva | 7, Sputum | 8, Whole blood | 90, Other, Specify",,,,,,RADx-UP Testing Core
covid_test_specimen_type_other,Covid Testing,text,Other specimen type,,,,,"[covid_test_specimen_type] = ""90""",,RADx-UP Testing Core
covid_test_specimen_collector,Covid Testing,radio,Specimen Collector,"1, Self-collect | 2, Health Care Provider collected | 90, Other, Specify",,,,,,RADx-UP Testing Core
covid_test_specimen_collector_other,Covid Testing,text,Other specimen collector,,,,,"[covid_test_specimen_collector] = ""90""",,RADx-UP Testing Core
covid_test_result_raw,Covid Testing,text,Raw test result (if not a Positive/Negative/Failed report),,,,,,,RADx-UP Testing Core
covid_test_result,Covid Testing,radio,Test result,"1, Positive | 2, Negative | 3, Failed | 4, Lost | 90, Other",,,,,,RADx-UP Testing Core
covid_test_result_other,Covid Testing,text,Other test result,,,,,"[covid_test_result] = ""90""",,RADx-UP Testing Core
covid_diagnosis,Covid Testing,radio,Have you ever been diagnosed with COVID-19?,"1, Yes | 0, No | 98,  not sure/prefer not to answer",,,,,,RADx-rad DCC
protocol_id,Technology metadata,text,Protocol id for the developed technology,,example: LIG_nPt_SA_hACE2_1.1.1,,,,,
technology_platform,Technology metadata,category,Name of the technology,ACE2 biosensor | ssDNA aptasensor | Immunosensor | multiplex | qRT-PCR,example: ACE2 biosensor,,,,,
technology_description,Technology metadata,text,Technology description,,example: impedimetric biosensor for detection of SARS-CoV-2 variants based on selective binding of spike protein on virus surface with truncated hACE2 immobilized on the surface of a working electrode,,,,,
technology_reference,Technology metadata,text,Publication DOI link for the platform.,,,,,,,
biorecognition_type,Technology Metadata,list,Type of molecular entity used for biosensor fabrication,aptamer | antibody | enzyme,Multiple entities can be specified as list if biosenor uses a combination of molecular entities,,,,,RADx-rad DCC
analyte_type,Technology Metadata,list,Type of analyte(s) or target(s) to be detected,antigen | genomic RNA | virus | antibody,example: virus,,,,,RADx-rad DCC
signal_detection,Technology Metadata,category,Type of signal generated by the methods or assay,"amperometric | chemiluminescent | chromatographic | colorimetric | fluorogenic | impedimetric ",example: impedietric,,,,,RADx-rad DCC
surface,Technology Metadata/Immobilization,text,Type of plate or electrode used in the methods or assay,,examples: polystyrene | gold electrode,,,,,RADx-rad DCC
electrochemical_method_name,Technology Metadata,category,Type of electrochemical technique performed to run the test,Cyclic voltammetry | Electrochemical impedance spectroscopy | DC potential amperometry | differential pulse voltammetry | diferencial pulse stripping voltammetry,example: Electrochemical impedance spectroscopy,,,,,
electrochemical_method_instrument,Technology Metadata,text,Tipe of instrument used to run the test,,example: Impedance analyzer,,,,,
electrochemical_method_settings,Technology Metadata,list,instrument settings used in electrochemical method,,"example: 0.01-10 Hz frequency range, 30 mV AC potential, etc",,,,,
electrochimical_method_mode,Technology Metadata,category,Operating mode applicable to the test,Faradaic | Non-Faradaic,example: Non-Faradaic,,,,,
electrochemical_method_solution,Technology Metadata,list,Name of electrolyte or buffer used in the test,PBS | isotonic saline| hypertonic saline,example: hypertonic saline,,,,,
electrochemical_method_solution_source,Technology Metadata,text,Information of manufacturer of the solution used in electrochemical experiments,,example: NeilMed® Sinus Rinse,,,,,https://shop.neilmed.com/products/sinus-rinse-100-regular-premixed-packets
reference_electrode,Technology Metadata,text,Type of reference electrode used in the electrochemical experiment,,example: Ag/AgCl,,,,,
auxiliary_electrode,Technology Metadata,text,Type of auxiliary (a.k.a counter) electrode used in the electrochemical experiment,,example: Pt wire,,,,,
working_electrode,Technology Metadata/Immobilization,text,Type of platform or electrode used in the methods or assay,,examples: platinum disk | gold electrode | graphene-platinum composite,,,,,RADx-rad DCC
immobilization_reagent_name,Technology Metadata/Immobilization,text,Reagent used to immobilize a capture probe to a surface,,example: glutaraldehyde| silica hydrogel,,,,,RADx-rad DCC
immobilization_reagent_id,Technology Metadata/Immobilization,text,Unique identifier or catalog number of immobilization reagent given by supplier,,example: W338605,,,,,RADx-rad DCC
immoblization_reagent_source,Technology Metadata/Immobilization,text,Supplier of reagent,,example: Sigma Aldrich,,,,,RADx-rad DCC
capture_receptor_id,Technology Metadata/Receptor,text,"Protein Sequence Database id, e.g., UniProt accession number or NCBI GenPept id",,examples: Q9BYF1,,,,,https://www.uniprot.org/ | https://www.ncbi.nlm.nih.gov/protein
capture_receptor_name,Technology Metadata/Receptor,text,UniProt preferred protein name,,example: Angiotensin-converting enzyme 2,,,,,RADx-rad DCC
capture_receptor_region,Technology Metadata/Receptor,text,Domain or subunit name,,example: ,,,,,RADx-rad DCC
capture_receptor_region_start,Technology Metadata/Receptor,integer,Start residue of region,,example: 18,,,,,RADx-rad DCC
capture_receptor_region_end,Technology Metadata/Receptor,integer,End residue of region,,example: 611,,,,,RADx-rad DCC
capture_receptor_modification,Technology Metadata/Receptor,list,Name of modification attached to the receptor,Biotin-tag | his-tag | thiol-tag,example: Biotin|HIS C-terminal,,,,,RADx-rad DCC
capture_receptor_expression_system,Technology Metadata/Receptor,category,System used to express protein,human-recombinant-baculovirus | human-recombinant-E.coli | human-recombinant-yeast| human-recombinant-mamalian,example: human-recombinant-mamalian,,,,,RADx-rad DCC
capture_receptor_formulation,Technology Metadata/Receptor,text,Formulation of receptor,,"example: pH: 7.4, constituents: 0.001% Zinc chloride, 0.32% Tris HCl, 10% Glycerol, 0.88% Sodium chloride",,,,,
capture_receptor_source,Technology Metadata/Receptor,text,Supplier of receptor or publication,,example: abcam,,,,,RADx-rad DCC
capture_receptor_source_id,Technology Metadata/Receptor,text,Unique identifier or catalog number of receptor given by supplier,,example: ab151852,,,,,
capture_receptor_source_name,Technology Metadata/Receptor,text,Name of receptor given by supplier,,example: Recombinant Human ACE2 protein,,,,,
capture_receptor_source_url,Technology Metadata/Antigen,url,URL of supplier catalog page or publication DOI link,,example: https://www.abcam.com/recombinant-human-ace2-protein-ab151852.html,,,,,RADx-rad DCC
capture_aptamer_id,Technology Metadata/Aptamer,text,Unique name or identifier for aptamer,,example: SNAP1,,,,,RADx-rad DCC
capture_aptamer_sequence,Technology Metadata/Aptamer,sequence,5' to 3' nucleic acid sequence,,example: TCGCTCTTTCCGCTTCTTCGCGGTCATTGTGCATCCTGACTGACCCTA,,,,,RADx-rad DCC
capture_aptamer_modification_5prime,Technology Metadata/Aptamer,text,Name of modification attached to the 5' end. This may include a spacer modification.,,examples: FITC | biotin-iSp18,,,,,RADx-rad DCC
capture_aptamer_modification_5prime_role,Technology Metadata/Aptamer,category,Role of the 5' modification,capturing | capturing + detection,,,,,,RADx-rad DCC
capture_aptamer_modification_3prime,Technology Metadata/Aptamer,text,Name of modification attached to the 5' end. This may include a spacer modification.,,,,,,,RADx-rad DCC
capture_aptamer_modification_3prime_role,Technology Metadata/Aptamer,category,Role of the 3' modification,capturing | capturing + detection,,,,,,RADx-rad DCC
capture_aptamer_formulation,Technology Metadata/Aptamer,text,Formulation of aptamer,,,,,,,RADx-rad DCC
capture_aptamer_source,Technology Metadata/Aptamer,text,Supplier or instrument used for synthesis,,,,,,,RADx-rad DCC
capture_aptamer_source_url,Technology Metadata/Aptamer,url,URL of supplier catalog page or publication DOI link,,example: https://doi.org/10.1002/anie.202107730,,,,,RADx-rad DCC
capture_aptamer_target_organism_name,Technology Metadata/Aptamer,text,NCBI organism name,,example: SARS-CoV-2,,,,,https://www.ncbi.nlm.nih.gov/taxonomy
capture_aptamer_target_organims_taxonomy_id,Technology Metadata/Aptamer,text,NCBI taxonomy id for organism,,example: 2697049,,,,,https://www.ncbi.nlm.nih.gov/taxonomy
capture_aptamer_target_organism_subtype,Technology Metadata/Aptamer,text,Subtype of organism,,example: H1N1 (for influenza),,,,,
capture_aptamer_target_protein_name,Technology Metadata/Aptamer,text,UniProt preferred protein name,,example: Spike glycoprotein,,,,,https://www.uniprot.org/
capture_aptamer_target_protein_id,Technology Metadata/Aptamer,text,UniProt accession number,,example: P0DTC2,,,,,https://www.uniprot.org/
capture_aptamer_target_protein_sequence,Technology Metadata/Aptamer,sequence,Protein sequence (if not available in UniProt),,,,,,,RADx-rad DCC
capture_aptamer_target_protein_region,Technology Metadata/Aptamer,text,Domain or subunit name,,example: Receptor Binding Domain,,,,,RADx-rad DCC
capture_aptamer_kd,Technology Metadata/Aptamer,float,Dissociation constant of aptamer with target,,,,,,nM,RADx-rad DCC
capture_aptamer_kon,Technology Metadata/Aptamer,float,On rate of aptamer with target,,,,,,,RADx-rad DCC
capture_aptamer_koff,Technology Metadata/Aptamer,float,Off rate of aptamer with target,,,,,,,RADx-rad DCC
capture_aptamer_kd_method,Technology Metadata/Aptamer,text,Method for ascertaining aptamer Kd,,,,,,,RADx-rad DCC
capture_antibody_id,Technology Metadata/Antibody,text,Unique identifier or catalog number of antibody given by supplier,,,,,,,RADx-rad DCC
capture_antibody_name,Technology Metadata/Antibody,text,Name of the capture antibody,,,,,,,RADx-rad DCC
capture_antibody_clonality,Technology Metadata/Antibody,category,Clonal state of the antibody,monoclonal | polyclonal,,,,,,RADx-rad DCC
capture_antibody_clone,Technology Metadata/Antibody,text,Name of the antibody clone,,,,,,,RADx-rad DCC
capture_antibody_modification,Technology Metadata/Antibody,text,Name of modification attached to the antibody,,,,,,,RADx-rad DCC
capture_antibody_modification_role,Technology Metadata/Antibody,category,Role of the modification,capturing | capturing + detection,,,,,,RADx-rad DCC
capture_antibody_expression_system,Technology Metadata/Antibody,category,Expression system used to express antibody,human-recombinant-baculovirus | human-recombinant-E.coli | human-recombinant-yeast| human-recombinant-mamalian,,,,,,RADx-rad DCC
capture_antibody_formulation,Technology Metadata/Antibody,text,Formulation of antibody,,,,,,,RADx-rad DCC
capture_antibody_source,Technology Metadata/Antibody,text,Supplier of the antibody or antibody conjugate or publication DOI link,,,,,,,RADx-rad DCC
capture_antibody_source_url,Technology Metadata/Antibody,url,URL of supplier catalog page or publication DOI link,,example:  https://doi.org/10.1002/anie.202107730,,,,,RADx-rad DCC
capture_antigen_id,Technology Metadata/Antigen,text,"Protein Sequence Database id, e.g., UniProt accession number or NCBI GenPept id",,examples: QHD43416.1,,,,,https://www.uniprot.org/ | https://www.ncbi.nlm.nih.gov/protein
capture_antigen_name,Technology Metadata/Antigen,text,UniProt preferred protein name,,example: Spike glycoprotein,,,,,RADx-rad DCC
capture_antigen_region,Technology Metadata/Antigen,text,Domain or subunit name,,example: Receptor Binding Domain,,,,,RADx-rad DCC
capture_antigen_region_start,Technology Metadata/Antigen,integer,Start residue number of region,,example: 319,,,,,RADx-rad DCC
capture_antigen_region_end,Technology Metadata/Antigen,integer,End residue number of region,,example: 591,,,,,RADx-rad DCC
capture_antigen_modification,Technology Metadata/Antigen,text,Name of modification attached to the antigen,,example: HIS; AVI,,,,,RADx-rad DCC
capture_antigen_expression_system,Technology Metadata/Antigen,category,System used to express protein,,,,,,,RADx-rad DCC
capture_antigen_source,Technology Metadata/Antigen,text,Supplier of antigen or publication,,GenScript,,,,,RADx-rad DCC
capture_antigen_source_url,Technology Metadata/Antigen,url,URL of supplier catalog page or publication DOI link,,example: https://www.genscript.com/protein/Z03483-SARS_CoV_2_Spike_protein_RBD_His_Tag_.html,,,,,RADx-rad DCC
sample_id,Sample,text,Unique identifier for a spiked (contrived) sample,,,,,,,
sample_media,Sample,text,Media used to prepare the spiked sample,,example: pooled saliva,,,,,
sample_media_id,Sample,text,"Catalog number, batch number, etc. for the sample media",,,,,,,
sample_media_provider,Sample,text,Entity that provided the sample media,,example: Lee Biosolutions,,,,,
sample_media_provider_url,Sample,text,URL of the sample media provider,,example: https://www.leebio.com/product/1769/saliva-pooled-human-donors-991-05-p-prec,,,,,
sample_concentration,Sample,float,Concentation of target analyte in the sample,,,,,,,
sample_concentration_unit,Sample,text,Unit of the sample concentration,,exmaple: copies/ml,,,,,
sample_group,Sample,category,Grouping of virus sample based on virus batch number and target organism name describe in the VQA panel.,"1, SARS-CoV-2 - WA1-UTI-001 | 2, SARS-CoV-2 - B.1.1.7-UTI-001 | 3, SARS-CoV-2 - B.1.351-UVI-001 | 4, SARS-CoV-2 - P1.UVI-001 | 5, SARS-CoV-2 - B.1.617.2-UVI-001 | 6, SARS-CoV-2 - BA.1-UVI-002 | 7, Human Coronavirus 229E - CoV229E-UVI-001 | 8, Human coronavirus OC43 - CoVOC43-UVI-001 | 9, RSVA2 - RSVA-UVI-001 | 10, RSVB - RSVB-UVI-001 | 11, Influenza A virus H3N2 - IAVH3N2-UVI-001 | 12, Influenza A virus H1N1 - 
IAVH1N1-UVI-001 | 13, Influenza B virus - IBV2009-UVI-001",,,,,,VQA panel
target_organism_name,Target,text,NCBI organism name,,example: SARS-CoV-2,,,,,https://www.ncbi.nlm.nih.gov/taxonomy
target_taxonomy_id,Target,text,NCBI taxonomy id for organism,,example: 2697049,,,,,https://www.ncbi.nlm.nih.gov/taxonomy
isolate_name,Target,text,Name of the isolate,,example: hCoV-19/USA/WA1/2020,,,,,
target_subtype,Target,text,Subtype of organism,,example (Influenza): H1N1,,,,,https://www.ncbi.nlm.nih.gov/taxonomy
gisaid_id,Target,text,GISAID isolate id of the original isolate,,example: EPI_ISL_751801,,,,,https://www.gisaid.org
gisaid_clade,Target,text,GISAID clade for SARS-CoV-2 variant,,example: GRY,,,,,https://www.gisaid.org
nucleotide_db_id,Target,text,"Nucleotide Sequence Database id, e.g., GenBank or ENA id of the original isolate",,example: MN985325.1,,,,,https://www.ncbi.nlm.nih.gov/genbank |  https://www.ebi.ac.uk/ena
pango_lineage,Target,text,Pango lineage for SARS-CoV-2 variant,,example: B.1.1.7,,,,,https://cov-lineages.org
who_label,Target,text,WHO label for SARS-CoV-2 variant,,example: Alpha,,,,,https://www.who.int/en/activities/tracking-SARS-CoV-2-variants
sample_test_variable,Sample,text,Response variable used as result for electrochemical testing.,,"example: impedance (real or imaginary), capacitance (real or imaginary)",,,,,
sample_test_variable_unit,Sample,text,Unit of the response variable in electrochemical testing.,,,,,,,
sample_test_result,Sample,float,Response variable measurement in electrochemical testing.,,,,,,,
target_analyte_type,Sample,list,Type of analyte(s) or target(s) to be detected,antigen | genomic RNA | inactivated virus | live virus | pseudovirus | antibody,example: antigen,,,,,
antigen_name,Sample/Antigen,text,UniProt preferred protein name,,example: Spike glycoprotein,,,,,
antigen_id,Sample/Antigen,text,"Protein Sequence Database id, e.g., UniProt accession number or NCBI GenPept id",,examples: P0DTC2|YP_009724390.1,,,,,https://www.uniprot.org/ | https://www.ncbi.nlm.nih.gov/protein
antigen_sequence,Sample/Antigen,sequence,Protein sequence if  protein sequence database id is unavailable,,,,,,,
antigen_nterminal_tag,Sample/Antigen,text,Name of tag attached to N-terminal,,example: HIS,,,,,
antigen_cterminal_tag,Sample/Antigen,text,Name of tag attached to C-terminal,,example: HIS,,,,,
antigen_region,Sample/Antigen,text,Domain or subunit name,,examples: S1|Receptor Binding Domain,,,,,
antigen_region_start,Sample/Antigen,integer,Start residue number of region,,example: 16,,,,,
antigen_region_end,Sample/Antigen,integer,End residue number of region,,example: 685,,,,,
antigen_expression_system,Sample/Antigen,text,System used to express protein,,,,,,,
antigen_formulation,Sample/Antigen,text,Formulation of antigen,,"example: Lyophilized from sterile PBS, pH 7.4.",,,,,
antigen_source,Sample/Antigen,text,Supplier of antigen or publication,,example: Sino Biological,,,,,
antigen_source_url,Sampe/Antigen,url,URL of supplier catalog page or publication DOI link,,example: https://www.sinobiological.com/recombinant-proteins/2019-ncov-cov-spike-40591-v08h,,,,,
antigen_concentration,Sample/Antigen,float,Protein concentration,,example: 1.0,,,,,
antigen_concentration_unit,Sample/Antigen,text,Unit of protein concentration,mM | uM| nM | pM | fM,example: nM,,,,,
limit_of_blank,Analytical Performance,float,"Limit of Blank (LOB).  The highest apparent analyte concentration expected to be found when a replicate of a sample containing no analyte are tested. Concentration units must be specified in the ""Units"" column! For qualitative tests.",,"Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S49-52. PMID: 18852857; PMCID: PMC2556583.",,,,,https://ncbi.nlm.nih.gov/pmc/articles/PMC2556583
limit_of_detection,Analytical Performance,float,"Limit of Detection (LOD). The minimum amount or concentration of analyte that can be reliably distinguished from zero. Concentration units must be specified in the ""Units"" column! For qualitative tests.",,"Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S49-52. PMID: 18852857; PMCID: PMC2556583.",,,,,https://ncbi.nlm.nih.gov/pmc/articles/PMC2556583
limit_of_detection_sn_ratio,Analytical Performance,float,Signal to noise ratio used to define the limit of detection in standard deviations.,,Example: 3,,,,,
limit_of_detection_detail,Analytical Performance,text,Description of how limit of detection was determined.,,"Example: A dilution series of heat inactivated SARS-CoV-2 virus stock (USA-WA1/2020) was prepared in natural clinical matrix (pooled nasopharyngeal swab samples eluted in VTM). Five (5) replicates were tested per dilution. The testing was performed as per the recommended instructions for use, with the virus in clinical matrix applied directly onto the Swab until the saturation of the flocked tip. The estimated LoD concentration for verification was selected as the concentration in between the dilution factor that returned 5/5 positive test outcomes (100%) and the next dilution factor that returned 0/5 positive (0%) based on the qualitative result. Source: https://www.fda.gov/media/144592/download.",,,,,
limit_of_quantitation,Analytical Performance,float,"Limit of Quantiation (LOQ). The minimum amount or concentration of analyte in the test sample that can be quantified with acceptable precision. Concentration units must be specified in the ""Units"" column! For quantiative tests.",,"Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S49-52. PMID: 18852857; PMCID: PMC2556583.",,,,,
limit_of_quantitation_sn_ratio,Analytical Performance,float,Signal to noise ratio used to define the limit of quantification in standard deviations.,,Example: 5,,,,,
limit_of_quantitation_detail,Analytical Performance,text,Description of how limit of quantition was determined.,,"
COVID-19 Home Test was tested with up to a concentration
of 106.43 TCID 50 /mL of heat inactivated SARS-CoV-2 virus
(USA-WA1/2020 Isolate). Source: https://www.fda.gov/media/144592/download.",,,,,
dynamic_range_min,Analytical Performance,float,,,,,,,,
dynamic_range_max,Analytical Performance,float,,,,,,,,
high_dose_hook_effect,Analytical Performance,text,Description of high dose hook effect.,,Example: No high dose hook effect was observed when the Ellume COVID-19 Home Test was tested with up to a concentration of 106.43 TCID 50 /mL of heat inactivated SARS-CoV-2 virus (USA-WA1/2020 Isolate). Source: https://www.fda.gov/media/144592/download.,,,,,https://www.olink.com/faq/what-is-the-high-dose-hook-effect/
non_clinical_sensitivity,Analytical Performance,float,The proportion of system-based positives; calculated as 100xTP/(TP+FN). Used for comparison with a VQA standard.,,,,,,,
non_clinical_selectivity,Analytical Performance,float,The proportion of system-based negatives; calculated as 100xTN/(TN+FP). Used for comparison with a VQA standard.,,,,,,,
area_under_the_roc_curve,Analytical/Clinical Performance,float,ROC-based performance. AUC under ROC curve.,,,,,,,
roc_x_values,Analytical/Clinical Performance,list,List of false positive rate values (1-specificity),,,,,,,
roc_y_values,Analytical/Clinical Performance,list,List of true positive rate values (sensitivity),,,,,,,
analytical_sensitivity,Analytical Performance,float,Analytical sensitivity is defined as the slope of the calibration curve.,,"Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S49-52. PMID: 18852857; PMCID: PMC2556583; https://www.youtube.com/watch?v=8Pe3k3fJNe8",,,,,
analytical_sensitivity_unit,Analytical Performance,text,Unit of analytical sensitivity,,,,,,,
analytical_inclusivity,Analytical Performance,text,Impact of variants/mutations on test results. Specificity with respect to variants/mutations compared to wildtype,,Analysis can be in silico and wet testing,,,,,
cross_reactivity_organism,Analytical Performance,text,Name of organism tested for cross-reactivity against target organism,,Example: Human coronavirus OC43,,,,,
cross_reactivity_organism_concentration,Analytical Performance,float,Concentration of cross-reacting organism.,,,,,,,
cross_reactivity_organism_concentration_unit,Analytical Performance,text,Concentation unit used for cross-reacting organism.,,Example: copies/ml,,,,,
cross_reactivity_result,Analytical Performance,category,Result of cross-reactivity test against target organism. A positive results indicates that cross-reacting organism gives a positive signal.,positive | negative | inconclusive,,,,,,
cross_reactivity_detail,Analytical Performance,text,Description of observed cross-reactivity.,,,,,,,
interfering_substance,Analytical Performance,text,Name of the interfering substance.,,Example: Menthol,,,,,
interfering_substance_provider,Analytical Performance,text,Name of the entity that provided the interfering substance.,,Example: Sigma Aldrich,,,,,
interfering_substance_concentration,Analytical Performance,list,Concentration of the interfering substance.,,Example: 1.5,,,,,
interfering_substance_concentation_unit,Analytical Performance,text,Concentration unit  used for interfering substance.,,"Examples: mg/ml, %v/v",,,,,
interfering_substance_detail,Analytical Performance,text,Description of observed interference.,,"Example:  There was no interference of SARS-CoV-2 detection
observed from any of the substances tested except for
bleach which was shown to interfere at the initial
concentration of 1% v/v tested. Further testing indicated that
the highest bleach level the test system could tolerate was
0.2% v/v. Source: https://www.fda.gov/media/144592/download.",,,,,
positive_percent_agreement,Analytical/Clinical Performance,float,Positive Percent Agreement (PPA). The proportion of non-reference standard positive subjects in whom the new test is positive.,,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
negative_percent_agreement,Analytical/Clinical Performance,float,Negative Percent Agreement (NPA). The proportion of non-reference standard negative subjects in whom the new test is negative.,,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
overall_percent_agreement,Analytical/Clinical Performance,float,"Percentage of total subjects where the
new test and the non-reference standard agree.",,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
target_condition,Clinical Performance,text,"A particular disease, a disease stage, health status, or any other identifiable condition within a patient, such as staging a disease already known to be present, or a health condition that should prompt clinical action, such as the initiation, modification, or termination of treatment.",,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
reference_standard,Clinical Performance,text,"The best available method for establishing the presence or absence of the target condition; the reference standard can be a single test or method, or a combination of methods and techniques, including clinical follow-up.",,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
study_population,Clinical Performance,text,The subjects/patients (and specimen types) included in the study,,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
stratification,Clinical Performance,text,"Stratification of subjects, e.g., days since onset of symptoms, asymptomatic vs. symptomatic, co-infections, PCR Cycle Threshold, n x LOD concentration ranges for contrived samples, number of subjects in each category in a separate data elements.",,,,,,,
true_positives,Clinical Performance,integer,True Positives (TP). The number of subjects/specimens with true positive test results,,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
false_positives,Clinical Performance,integer,False Positives (FP). The number of subjects/specimens with false positive test results,,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
true_negatives,Clinical Performance,integer,True Negatives (TN). The number of subjects/specimens with true negative test results.,,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
false_negatives,Clinical Performance,integer,False Negatives (FN). The number of subjects/specimens with false negative test results,,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
clinical_sensitivity,Clinical Performance,float,The proportion of subjects with the target condition in whom the test is positive; calculated as 100xTP/(TP+FN). Used for comparison with a reference (Gold) standard.,,PCR is Gold standard for COVID-19. For comparison with a non-reference standard use percent agreement metrics.,,,,,
clinical_sensitiviy_ci_percent,Clinical Performance,float,Percent used to define two-sided confidence interval.,,Example: 95,,,,,
clinical_sensitivity_ci_min,Clinical Performance,float,Lower bound of confidence interval.,,,,,,,
clinical_sensitvity_ci_max,Clinical Performance,float,Upper bound of confidence interval.,,,,,,,
clinical_specificity,Clinical Performance,float,The proportion of subjects without the target condition in whom the test is negative; calculated as 100xTN/(FP+TN).,,PCR is Gold standard for COVID-19. For comparison with a non-reference standard use percent agreement metrics.,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
positive_predictive_value,Clinical Performance,float,The proportion of test positive patients who have the target condition; calculated as 100xTP/(TP+FP),,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
negative_predictive_value,Clinical Performance,float,The proportion of test negative patients who do not have the target condition; calculated as 100xTN/(TN+FN),,,,,,,https://www.fda.gov/files/medical%20devices/published/Guidance-for-Industry-and-FDA-Staff---Statistical-Guidance-on-Reporting-Results-from-Studies-Evaluating-Diagnostic-Tests-%28PDF-Version%29.pdf
clinical_cutoff,Clinical Performance,float,,,,,,,,
invalid_test_rate,Clinical Performance,float,,,,,,,,
invalid_test_detail,Clinical Performance,text,,,,,,,,
turnaround_time,Clinical Performance,integer,TAT,,,,,,minutes,
turnaround_time_unit,Clinical Performance,text,Unit for technology turnaround time.,,"example: seconds, minutes, hours.",,,,,
price_per_test,Clinical Performance,float,,,,,,,USD,
virus_sample_id,Sample/Virus,text,Supplier catalog number or identifier,,example (BEI Resources): NR-52286,,,,,
virus_batch_id,Sample/Virus,text,Batch and or/lot number of virus sample,,,,,,,
virus_sample_formulation,Sample/Virus,text,Formulation of virus sample,,"example: Strain diluted in cell culture
media (DMEM + 1% FBS + 10mM HEPES + 50 units/ml Penicillin and 50 ug/ml Streptomycin).",,,,,
virus_sample_provider,Sample/Virus,text,Provider from where the inactivated virus sample was procured from,,examples: UCSD|BEI Resources|ATCC,,,,,
virus_sample_provider_url,Sample/Virus,url,URL of supplier catalog page or publication DOI link,,example:  https://www.beiresources.org/Catalog/animalviruses/NR-52281.aspx,,,,,
virus_source,Sample/Virus,text,Source of the live virus,,"examples: BEI Resources, UCSD ",,,,,
virus_location,Sample/Virus,text,Location where the virus sample was collected,,,,,,,
virus_sample_type,Sample/Virus,category,Type of virus sample,inactivated virus | life virus,example: inactivated virus,,,,,
virus_sample_inactivation_method,Sample/Virus,category,Method of virus inactivation,UV | heat | Gamma-irradiated,example: heat,,,,,
virus_sample_formulation,Sample/Virus,text,Formulation (media) of virus sample,,,,,,,
virus_sample_concentration,Sample/Virus,float,Concentration of virus (gene copies/ml),,example: 1.16E+09,,,,copies/ml,
virus_sample_concentration_reference_gene,Sample/Virus,text,Reference gene used to determine concentration of virus,,example: ORF1a|N,,,,,
virus_sample_tcid50,Sample/Virus,float,Tissue Culture Infectious Dose 50% (TCID50) endpoint is the 50% infectious endpoint in cell culture. The TCID50 is the dilution of virus that under the conditions of the assay can be expected to infect 50% of the culture vessels inoculated. (TCID50/ml),,,,,,TCID50/ml,https://www.beiresources.org
virus_sample_tcid_cell_line,Sample/Virus,text,Cell line used for producing virus,,example: Calu-3,,,,,
